MDR1 T-129C Polymorphism can be Predictive of Differentiation, and Thereby Prognosis of Colorectal Adenocarcinomas in Japanese

  • Koyama Tatsuya
    Division of Clinical Pharmacokinetics, Department of General Therapeutics, Faculty of Medicine & Division of Biomedical Sciences, Kobe University Graduate School of Medicine
  • Nakamura Tsutomu
    Department of Hospital Pharmacy, School of Medicine, Kobe University
  • Komoto Chiho
    Department of Hospital Pharmacy, School of Medicine, Kobe University
  • Sakaeda Toshiyuki
    Division of Clinical Pharmacokinetics, Department of General Therapeutics, Faculty of Medicine & Division of Biomedical Sciences, Kobe University Graduate School of Medicine Department of Hospital Pharmacy, School of Medicine, Kobe University
  • Taniguchi Mayuko
    Division of Clinical Pharmacokinetics, Department of General Therapeutics, Faculty of Medicine & Division of Biomedical Sciences, Kobe University Graduate School of Medicine
  • Okamura Noboru
    Department of Clinical Evaluation of Pharmacotherapy, Kobe University Graduate School of Medicine
  • Tamura Takao
    Division of Diabetes, Digestive and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine
  • Aoyama Nobuo
    Department of Endoscopy, School of Medicine, Kobe University
  • Kamigaki Takashi
    Division of Gastroenterological Surgery, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine
  • Kuroda Yoshikazu
    Division of Gastroenterological Surgery, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine
  • Kasuga Masato
    Division of Diabetes, Digestive and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine
  • Kadoyama Keiichi
    Division of Molecular Regenerative Medicine, Department of Biochemistry and Molecular Biology, Osaka University Graduate School of Medicine
  • Okumura Katsuhiko
    Division of Clinical Pharmacokinetics, Department of General Therapeutics, Faculty of Medicine & Division of Biomedical Sciences, Kobe University Graduate School of Medicine Department of Hospital Pharmacy, School of Medicine, Kobe University Department of Clinical Evaluation of Pharmacotherapy, Kobe University Graduate School of Medicine

この論文をさがす

抄録

The expression level of MDR1 mRNA was evaluated in colorectal adenocarcinomas and adjacent noncancerous colorectal tissues obtained from 21 Japanese patients. It was lower in the former than in the latter (p=0.012), suggesting its down-regulation as a consequence of malignant transformation of colorectal tissues, possibly with the suppression of differentiation. Relatively lower expression was suggested in moderately-differentiated colorectal adenocarcinomas than well-differentiated ones, but there was no statistical difference (p=0.111). MDR1 mRNA up-regulation was found in a colorectal adenocarcinoma cell line, HCT-15, after treatment with two typical differentiating agents, sodium butyrate and all-trans retinoic acid, suggesting its involvement in the cellular events, resulting in differentiation without malignant transformation. MDR1 T-129C, but not G2677A,T and C3435T, was associated with the lower expression of MDR1 mRNA both in colorectal adenocarcinomas (p=0.040) and adjacent noncancerous colorectal tissues (p=0.023), possibly being an useful invasive marker predicting poorly-differentiated colorectal adenocarcinomas and thereby the poor prognosis of the patients, especially when no extra biopsy samples will be obtained. Further investigations with relatively large number of patients should be undertaken to confirm these preliminary results.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (57)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ